Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 5, 2023 (Week 31)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 15,673 33,774 838,295 979,683
New England 163 1,650 23,417 31,238
Connecticut - 430 1,155 7,297
Maine 52 77 1,744 1,912
Massachusetts - 709 15,463 16,657
New Hampshire - 82 1,337 1,806
Rhode Island 90 694 2,908 2,823
Vermont 21 37 810 743
Middle Atlantic 2,860 4,218 115,422 114,101
New Jersey 500 788 20,404 19,688
New York (excluding New York City) 900 1,032 24,408 23,357
New York City 760 1,457 38,864 38,292
Pennsylvania 700 1,233 31,746 32,764
East North Central 1,706 5,878 111,963 168,840
Illinois 84 1,811 29,668 42,294
Indiana 241 858 16,779 19,918
Michigan 271 975 19,061 25,195
Ohio 671 2,294 31,686 65,852
Wisconsin 439 561 14,769 15,581
West North Central 781 2,165 54,543 60,436
Iowa 159 334 8,016 8,796
Kansas 96 337 5,818 8,425
Minnesota 100 497 12,683 13,271
Missouri 397 729 18,522 19,014
Nebraska - 220 4,902 5,763
North Dakota - 92 1,759 2,119
South Dakota 29 125 2,843 3,048
South Atlantic 3,646 7,252 192,932 204,330
Delaware 138 420 3,398 6,192
District of Columbia - 191 3,996 4,841
Florida 1,792 2,786 64,862 62,929
Georgia 304 1,596 40,734 43,527
Maryland U NC U U
North Carolina 8 1,440 32,899 38,972
South Carolina 658 884 19,757 21,632
Virginia 718 976 24,768 23,526
West Virginia 28 104 2,518 2,711
East South Central 1,209 2,448 59,553 66,342
Alabama 600 972 20,521 18,226
Kentucky 404 555 9,663 10,772
Mississippi 2 488 10,067 14,189
Tennessee 203 1,094 19,302 23,155
West South Central 654 5,295 83,220 150,712
Arkansas 201 804 9,425 21,433
Louisiana 401 794 20,658 21,869
Oklahoma 52 422 6,397 11,699
Texas - 3,398 46,740 95,711
Mountain 1,618 2,523 61,334 69,860
Arizona 512 918 23,519 24,562
Colorado 720 651 15,513 15,420
Idaho 66 155 3,409 3,361
Montana 43 100 1,690 2,497
Nevada 28 367 4,470 9,623
New Mexico - 257 5,167 6,709
Utah 205 252 6,606 6,681
Wyoming 44 54 960 1,007
Pacific 3,036 5,047 135,911 113,824
Alaska 59 121 2,406 3,247
California 2,328 4,112 112,749 80,237
Hawaii - 142 - 3,267
Oregon 214 362 8,895 9,428
Washington 435 635 11,861 17,645
U.S. Territories - 124 1,138 2,813
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 2,813
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 2 7 36 85
Total 15,675 33,874 839,469 982,581
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.